361 Capital’s Ingevity NGVT Stock Holding History

361 Capital’s Portfolio NGVT Stock Details NGVT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-32,141	Closed	-$2.73M	–	380
2019 Q3	$2.73M	Buy	+32,141	New	+$2.86M	0.5%	48
2019 Q2	–	Sell	-24,576	Closed	-$2.6M	–	365
2019 Q1	$2.6M	Buy	+24,576	New	+$2.47M	0.45%	110

Other funds holding NGVT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

361 Capital's NGVT Position: Q4 2019 in Review

361 Capital sold out of Ingevity (NGVT) in Q4 2019, closing a stake of 32,141 shares — an estimated $2.73M sold.

361 Capital first reported a position in NGVT in Q1 2019 and held it in 2 quarters. The position peaked at $2.73M in Q3 2019. 334 funds tracked by Wall St. Rank hold NGVT as of Q4 2019.

361 Capital reported no remaining Ingevity position as of Q4 2019 after selling out during the quarter.
361 Capital sold 32,141 Ingevity shares in Q4 2019, an estimated $2.73M.
361 Capital first reported a position in Ingevity in Q1 2019 and held it in 2 quarters.
361 Capital's Ingevity position peaked at $2.73M in Q3 2019.
334 funds tracked by Wall St. Rank held Ingevity as of Q4 2019.

Based on 361 Capital's 13F filing for Q4 2019, filed 13 Feb 2020.